May 2026
1. HU X, Yang X, Jin P, Tian J, et al
   A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non-Small Cell Lung Cancer.
   Mol Carcinog. 2026 May 15. doi: 10.1002/mc.70124.
   

   >> Share

   
   April 2026
2. CASTILLO-SANCHEZ R, Ordonez-Moreno A, Torres-Alamilla P, Cortes-Reynosa P, et al
   PI3K Activity Mediates the Epithelial to Mesenchymal Transition Process in MCF10A Cells and Tumor Growth and Metastasis in a Murine Model of Breast Cancer.
   Mol Carcinog. 2026;65:434-447.
   

   >> Share

   
   March 2026
3. SU G, Yang S, Fan B, Jiang Z, et al
   Long Non-Coding RNA PTPRG-AS1 Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells via Modulation of the IGF1/PI3K/AKT Signaling Pathway.
   Mol Carcinog. 2026 Mar 30. doi: 10.1002/mc.70073.
   

   >> Share

   
   January 2026
4. REDDY JP, Clague RA, Peixoto BP, Bernstein S, et al
   Lung Cancer Cells Secrete Glutamine to Accumulate Tumor-Associated Macrophages.
   Mol Carcinog. 2026 Jan 7. doi: 10.1002/mc.70077.
   

   >> Share

   
   December 2025
5. CHEN Y, Yu Y, Sun Q, Zhu X, et al
   Helicobacter pylori Infection, Metabolomic Signature and Extra-gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis.
   Mol Carcinog. 2025;64:2086-2101.
   

   >> Share

   
   October 2025
6. WANG W, Tian S, Ou Y, Yang J, et al
   FBXW5 Promotes Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Through the KLF13/TROAP Signaling Pathway.
   Mol Carcinog. 2025;64:1638-1649.
   

   >> Share

   
   September 2025
7. XU S, Chen C, Liu H, Jiang S, et al
   Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1-Mediated Cell Adhesion via the PI3K/AKT Pathway.
   Mol Carcinog. 2025;64:1564-1579.
   

   >> Share

   
   
8. QIAN D, Zha D, Sang Y, Tao J, et al
   A-to-I RNA Edited miR-3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2-Meditated Hippo Signaling.
   Mol Carcinog. 2025;64:1552-1563.
   

   >> Share

   
   July 2025
9. LU M, Wan T, Huang Q, Yao J, et al
   Determine the Antimetastasis Effect of Artesunate in Lung Cancer-Driven Brain Metastasis Model.
   Mol Carcinog. 2025 Jul 6. doi: 10.1002/mc.70010.
   

   >> Share

   
   
10. LIU Z, Lenz HJ, Yu J, Zhang L, et al
    Differential Response and Resistance to KRAS-Targeted Therapy.
    Mol Carcinog. 2025;64:1135-1148.
    

    >> Share

    
    
11. GONG Z, Yu F, Li C, Zhao B, et al
    Four-gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma.
    Mol Carcinog. 2025;64:1209-1221.
    

    >> Share

    
    June 2025
12. CAO L, Xu H, Zhang A, Gao L, et al
    LINC02562 Promotes Progression of Lung Cancer by Regulating NTHL1 Dependent DNA Damage Repair Mechanisms.
    Mol Carcinog. 2025 Jun 11. doi: 10.1002/mc.23935.
    

    >> Share

    
    May 2025
13. LI X, Wu Y, Xie B, Xu M, et al
    SPP1 Promotes NSCLC Brain Metastasis Via Sequestration of Ubiquitin Ligase RNF114 to Facilitate P85alpha Ubiquitination.
    Mol Carcinog. 2025;64:829-841.
    

    >> Share

    
    March 2025
14. MAO S, Li Q, Yang Y, Liu Z, et al
    Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis-Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non-Small Cell Lung Cancer.
    Mol Carcinog. 2025 Mar 4. doi: 10.1002/mc.23899.
    

    >> Share

    
    January 2025
15. GENG Y, Yin T, Li Y, He K, et al
    Computed Tomography-Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non-Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy.
    Mol Carcinog. 2025 Jan 21. doi: 10.1002/mc.23883.
    

    >> Share

    
    
16. LIANG H, Zhang C, Hu M, Hu F, et al
    ALKBH5-Mediated m(6)A Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.
    Mol Carcinog. 2025;64:57-71.
    

    >> Share

    
    November 2024
17. ZHANG Y, Wang Y, Weng J, Chen J, et al
    Pyroptosis-related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma.
    Mol Carcinog. 2024;63:2218-2236.
    

    >> Share

    
    
18. QIU R, Deng Y, Lu Y, Liu X, et al
    ITGB3-enriched extracellular vesicles mediate the formation of osteoclastic pre-metastatic niche to promote lung adenocarcinoma bone metastasis.
    Mol Carcinog. 2024;63:2190-2204.
    

    >> Share

    
    July 2024
19. YANG Q, Sun K, Gao T, Gao Y, et al
    SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK/mTOR/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells.
    Mol Carcinog. 2024 Jul 30. doi: 10.1002/mc.23799.
    

    >> Share

    
    
20. LAI Q, Wan Y, Zhang Y, Huang Y, et al
    Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Mol Carcinog. 2024;63:1260-1274.
    

    >> Share

    
    June 2024
21. DENG Z, Dou L, Luo Z, Liu R, et al
    AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells.
    Mol Carcinog. 2024 Jun 24. doi: 10.1002/mc.23781.
    

    >> Share

    
    
22. LIANG X, Xu J, Jiang Y, Yan Y, et al
    Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.
    Mol Carcinog. 2024 Jun 11. doi: 10.1002/mc.23750.
    

    >> Share

    
    May 2024
23. CHEN C, Tang D, Xu S, Xiang L, et al
    The promotion of non-small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species.
    Mol Carcinog. 2024 May 10. doi: 10.1002/mc.23736.
    

    >> Share

    
    
24. DU X, Cheng C, Yang Y, Fan B, et al
    NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m(5)C-dependent manner.
    Mol Carcinog. 2024;63:962-976.
    

    >> Share

    
    
25. YANG Y, Tian Z, He L, Meng H, et al
    RhoGDIbeta inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
    Mol Carcinog. 2024;63:977-990.
    

    >> Share

    
    February 2024
26. FURUSAWA T, Cavero R, Liu Y, Li H, et al
    Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.
    Mol Carcinog. 2024 Feb 27. doi: 10.1002/mc.23705.
    

    >> Share

    
    
27. LI Q, Li J, Wang J, Wang J, et al
    PLEK2 mediates metastasis and invasion via alpha5-nAChR activation in nicotine-induced lung adenocarcinoma.
    Mol Carcinog. 2024;63:253-265.
    

    >> Share

    
    
28. HU M, Cheng H, Yang Y, Xu L, et al
    Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co-mutated lung cancers and downregulated mutant-p53 levels.
    Mol Carcinog. 2024;63:275-285.
    

    >> Share

    
    January 2024
29. LI J, Li Y, Sun X, Wei L, et al
    Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
    Mol Carcinog. 2024 Jan 30. doi: 10.1002/mc.23686.
    

    >> Share

    
    
30. ZHANG X, Zhao Y, Yiminniyaze R, Zhu N, et al
    CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Mol Carcinog. 2024;63:61-74.
    

    >> Share

    
    December 2023
31. HUA T, Zhang C, Fu Y, Qin N, et al
    Integrative analyses of N6-methyladenosine-associated single-nucleotide polymorphisms (m6A-SNPs) identify tumor suppressor gene AK9 in lung cancer.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23669.
    

    >> Share

    
    
32. JIANG T, Li N, Xu H, Sun L, et al
    Identification of ATAD3A as a key regulator in non-small cell lung cancer by promoting STAT3-induced cell proliferation and tumor angiogenesis.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23667.
    

    >> Share

    
    
33. ZHANG C, Sun Q, Zhao J, Jiang N, et al
    JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
    Mol Carcinog. 2023;62:1888-1901.
    

    >> Share

    
    November 2023
34. CHEN J, Kang G, Lei W, Li J, et al
    DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer.
    Mol Carcinog. 2023 Nov 8. doi: 10.1002/mc.23654.
    

    >> Share

    
    
35. QIAO R, Zhu Q, Di F, Liu C, et al
    Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk.
    Mol Carcinog. 2023;62:1745-1754.
    

    >> Share

    
    
36. WANG B, Shen XY, Pan LY, Li Z, et al
    The HDAC2-MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c-Myc and cyclin D1.
    Mol Carcinog. 2023;62:1630-1644.
    

    >> Share

    
    October 2023
37. LONG T, Li J, Yin T, Liu K, et al
    A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
    Mol Carcinog. 2023 Oct 3. doi: 10.1002/mc.23642.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share